-
1
-
-
0344667547
-
Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway
-
Baumann R, Casaulta C, Simon D, Conus S, Yousefi S, Simon HU: Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 2003;17:2221-2230.
-
(2003)
FASEB J
, vol.17
, pp. 2221-2230
-
-
Baumann, R.1
Casaulta, C.2
Simon, D.3
Conus, S.4
Yousefi, S.5
Simon, H.U.6
-
2
-
-
20444403798
-
Apoptotic pathways are inhibited by leptin receptor activation in neutrophils
-
Bruno A, Conus S, Schmid I, Simon HU: Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol 2005;174:8090-8096.
-
(2005)
J Immunol
, vol.174
, pp. 8090-8096
-
-
Bruno, A.1
Conus, S.2
Schmid, I.3
Simon, H.U.4
-
3
-
-
23044477087
-
Leukocyte apoptosis and its significance in sepsis and shock
-
Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A: Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 2005;78:325-337.
-
(2005)
J Leukoc Biol
, vol.78
, pp. 325-337
-
-
Wesche, D.E.1
Lomas-Neira, J.L.2
Perl, M.3
Chung, C.S.4
Ayala, A.5
-
4
-
-
0037438678
-
A role for apoptosis in the control of neutrophil homeostasis in the circulation: Insights from CD18-deficient mice
-
Weinmann P, Scharffetter-Kochanek K, Forlow SB, Peters T, Walzog B: A role for apoptosis in the control of neutrophil homeostasis in the circulation: insights from CD18-deficient mice. Blood 2003;101:739-746.
-
(2003)
Blood
, vol.101
, pp. 739-746
-
-
Weinmann, P.1
Scharffetter-Kochanek, K.2
Forlow, S.B.3
Peters, T.4
Walzog, B.5
-
5
-
-
0035808270
-
Molecular control of neutrophil apoptosis
-
Akgul C, Moulding DA, Edwards SW: Molecular control of neutrophil apoptosis. FEBS Lett 2001;487:318-322.
-
(2001)
FEBS Lett
, vol.487
, pp. 318-322
-
-
Akgul, C.1
Moulding, D.A.2
Edwards, S.W.3
-
6
-
-
0033539507
-
Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: A general mechanism to accumulate effector cells in inflammation
-
Dibbert B, Weber M, Nikolaizik WH, Vogt P, Schoni MH, Blaser K, Simon HU: Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci USA 1999;96:13330-13335.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 13330-13335
-
-
Dibbert, B.1
Weber, M.2
Nikolaizik, W.H.3
Vogt, P.4
Schoni, M.H.5
Blaser, K.6
Simon, H.U.7
-
7
-
-
0035213274
-
BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis
-
Moulding DA, Akgul C, Derouet M, White MR, Edwards SW: BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J Leukoc Biol 2001;70:783-792.
-
(2001)
J Leukoc Biol
, vol.70
, pp. 783-792
-
-
Moulding, D.A.1
Akgul, C.2
Derouet, M.3
White, M.R.4
Edwards, S.W.5
-
8
-
-
0034605032
-
Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes
-
Villunger A, O'Reilly LA, Holler N, Adams J, Strasser A: Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: regulators of distinct cell death and survival pathways in granulocytes. J Exp Med 2000;192:647-658.
-
(2000)
J Exp Med
, vol.192
, pp. 647-658
-
-
Villunger, A.1
O'Reilly, L.A.2
Holler, N.3
Adams, J.4
Strasser, A.5
-
9
-
-
2442666527
-
Bid truncation, bid/bax targeting to the mitochondria, and caspase activation associated with neutrophil apoptosis are inhibited by granulocyte colony-stimulating factor
-
Maianski NA, Roos D, Kuijpers TW: Bid truncation, bid/bax targeting to the mitochondria, and caspase activation associated with neutrophil apoptosis are inhibited by granulocyte colony-stimulating factor. J Immunol 2004;172:7024-7030.
-
(2004)
J Immunol
, vol.172
, pp. 7024-7030
-
-
Maianski, N.A.1
Roos, D.2
Kuijpers, T.W.3
-
10
-
-
0023871477
-
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy
-
Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R: Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988;i:667-672.
-
(1988)
Lancet
, vol.1
, pp. 667-672
-
-
Morstyn, G.1
Campbell, L.2
Souza, L.M.3
Alton, N.K.4
Keech, J.5
Green, M.6
Sheridan, W.7
Metcalf, D.8
Fox, R.9
-
11
-
-
0027936785
-
In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro
-
Adachi S, Kubota M, Lin YW, Okuda A, Matsubara K, Wakazono Y, Hirota H, Kuwakado K, Akiyama Y: In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro. Eur J Haematol 1994;53:129-134.
-
(1994)
Eur J Haematol
, vol.53
, pp. 129-134
-
-
Adachi, S.1
Kubota, M.2
Lin, Y.W.3
Okuda, A.4
Matsubara, K.5
Wakazono, Y.6
Hirota, H.7
Kuwakado, K.8
Akiyama, Y.9
-
12
-
-
19444387158
-
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function
-
Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, Watson RW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function. Pediatr Res 2005;57:806-812.
-
(2005)
Pediatr Res
, vol.57
, pp. 806-812
-
-
Molloy, E.J.1
O'Neill, A.J.2
Grantham, J.J.3
Sheridan-Pereira, M.4
Fitzpatrick, J.M.5
Webb, D.W.6
Watson, R.W.7
-
13
-
-
0037079734
-
Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils
-
Maianski NA, Mul FP, van Buul JD, Roos D, Kuijpers TW: Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 2002;99:672-679.
-
(2002)
Blood
, vol.99
, pp. 672-679
-
-
Maianski, N.A.1
Mul, F.P.2
van Buul, J.D.3
Roos, D.4
Kuijpers, T.W.5
-
14
-
-
2542466891
-
Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils
-
Altznauer F, Martinelli S, Yousefi S, Thurig C, Schmid I, Conway EM, Schoni MH, Vogt P, Mueller C, Fey MF, Zangemeister-Wittke U, Simon HU: Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 2004;199:1343-1354.
-
(2004)
J Exp Med
, vol.199
, pp. 1343-1354
-
-
Altznauer, F.1
Martinelli, S.2
Yousefi, S.3
Thurig, C.4
Schmid, I.5
Conway, E.M.6
Schoni, M.H.7
Vogt, P.8
Mueller, C.9
Fey, M.F.10
Zangemeister-Wittke, U.11
Simon, H.U.12
-
15
-
-
0028329172
-
Apoptosis. Its significance in cancer and cancer therapy
-
Kerr JF, Winterford CM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73:2013-2026.
-
(1994)
Cancer
, vol.73
, pp. 2013-2026
-
-
Kerr, J.F.1
Winterford, C.M.2
Harmon, B.V.3
-
16
-
-
0029799801
-
Study of apoptosis in peripheral blood of patients with acute lymphoblastic leukemia during induction therapy
-
Tsangaris GT, Moschovi M, Mikraki V, Vrachnou E, Tzortzatou-Stathopoulou F: Study of apoptosis in peripheral blood of patients with acute lymphoblastic leukemia during induction therapy. Anticancer Res 1996;16:3133-3140.
-
(1996)
Anticancer Res
, vol.16
, pp. 3133-3140
-
-
Tsangaris, G.T.1
Moschovi, M.2
Mikraki, V.3
Vrachnou, E.4
Tzortzatou-Stathopoulou, F.5
-
17
-
-
0030999750
-
Apoptosis and the dilemma of cancer chemotherapy
-
Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 1997;89:1845-1853.
-
(1997)
Blood
, vol.89
, pp. 1845-1853
-
-
Hannun, Y.A.1
-
18
-
-
0032125905
-
Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy
-
Kamesaki H: Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy. Int J Hematol 1998;68:29-43.
-
(1998)
Int J Hematol
, vol.68
, pp. 29-43
-
-
Kamesaki, H.1
-
19
-
-
0032962588
-
Apoptosis and therapy
-
Schmitt CA, Lowe SW: Apoptosis and therapy. J Pathol 1999;187:127-137.
-
(1999)
J Pathol
, vol.187
, pp. 127-137
-
-
Schmitt, C.A.1
Lowe, S.W.2
-
20
-
-
0034630167
-
Induction of apoptosis by cancer chemotherapy
-
Kaufmann SH, Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000;256:42-49.
-
(2000)
Exp Cell Res
, vol.256
, pp. 42-49
-
-
Kaufmann, S.H.1
Earnshaw, W.C.2
-
21
-
-
0033998656
-
Enhanced ex vivo apoptosis of peripheral granulocytes is a sufficient factor of neutropenia following myeloablative chemotherapy
-
Chukhlovin A: Enhanced ex vivo apoptosis of peripheral granulocytes is a sufficient factor of neutropenia following myeloablative chemotherapy. Leuk Res 2000;24:507-509.
-
(2000)
Leuk Res
, vol.24
, pp. 507-509
-
-
Chukhlovin, A.1
-
22
-
-
7444221235
-
Fluorouracil induces apoptosis and surface molecule modulation of peripheral blood leukocytes
-
Kimhi O, Drucker L, Neumann A, Shapiro H, Shapira J, Yarkoni S, Lahav M, Radnay J, Lishner M: Fluorouracil induces apoptosis and surface molecule modulation of peripheral blood leukocytes. Clin Lab Haematol 2004;26:327-333.
-
(2004)
Clin Lab Haematol
, vol.26
, pp. 327-333
-
-
Kimhi, O.1
Drucker, L.2
Neumann, A.3
Shapiro, H.4
Shapira, J.5
Yarkoni, S.6
Lahav, M.7
Radnay, J.8
Lishner, M.9
-
23
-
-
0032863268
-
Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro
-
Lejeune M, Cantinieaux B, Harag S, Ferster A, Devalck C, Sariban E: Defective functional activity and accelerated apoptosis in neutrophils from children with cancer are differentially corrected by granulocyte and granulocyte-macrophage colony stimulating factors in vitro. Br J Haematol 1999;106:756-761.
-
(1999)
Br J Haematol
, vol.106
, pp. 756-761
-
-
Lejeune, M.1
Cantinieaux, B.2
Harag, S.3
Ferster, A.4
Devalck, C.5
Sariban, E.6
-
24
-
-
0032745325
-
A new form of filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans
-
Molineux G, Kinstler O, Briddell B, Hartley C, McElroy P, Kerzic P, Sutherland W, Stoney G, Kern B, Fletcher FA, Cohen A, Korach E, Ulich T, McNiece I, Lockbaum P, Miller-Messana MA, Gardner S, Hunt T, Schwab G: A new form of filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp Hematol 1999;27:1724-1734.
-
(1999)
Exp Hematol
, vol.27
, pp. 1724-1734
-
-
Molineux, G.1
Kinstler, O.2
Briddell, B.3
Hartley, C.4
McElroy, P.5
Kerzic, P.6
Sutherland, W.7
Stoney, G.8
Kern, B.9
Fletcher, F.A.10
Cohen, A.11
Korach, E.12
Ulich, T.13
McNiece, I.14
Lockbaum, P.15
Miller-Messana, M.A.16
Gardner, S.17
Hunt, T.18
Schwab, G.19
-
25
-
-
0037250159
-
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
-
Green MD, Koelbl H, Baselga J, Galid A, Guillem V, Gascon P, Siena S, Lalisang RI, Samonigg H, Clemens MR, Zani V, Liang BC, Renwick J, Piccart MJ: A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol 2003;14:29-35.
-
(2003)
Ann Oncol
, vol.14
, pp. 29-35
-
-
Green, M.D.1
Koelbl, H.2
Baselga, J.3
Galid, A.4
Guillem, V.5
Gascon, P.6
Siena, S.7
Lalisang, R.I.8
Samonigg, H.9
Clemens, M.R.10
Zani, V.11
Liang, B.C.12
Renwick, J.13
Piccart, M.J.14
-
26
-
-
0036467835
-
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer
-
Holmes FA, O'Shaughnessy JA, Vukelja S, Jones SE, Shogan J, Savin M, Glaspy J, Moore M, Meza L, Wiznitzer I, Neumann TA, Hill LR, Liang BC: Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol 2002;20:727-731.
-
(2002)
J Clin Oncol
, vol.20
, pp. 727-731
-
-
Holmes, F.A.1
O'Shaughnessy, J.A.2
Vukelja, S.3
Jones, S.E.4
Shogan, J.5
Savin, M.6
Glaspy, J.7
Moore, M.8
Meza, L.9
Wiznitzer, I.10
Neumann, T.A.11
Hill, L.R.12
Liang, B.C.13
-
27
-
-
0003871544
-
-
Ethical principles for medical research involving human subjects
-
World Medical Association: World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. http://www.wma.net/e/policy/b3.htm.
-
World Medical Association Declaration of Helsinki
-
-
-
28
-
-
0029835016
-
In situ apoptotic cell labeling by the TUNEL method: Improvement and evaluation on cell preparations
-
Negoescu A, Lorimier P, Labat-Moleur F, Drouet C, Robert C, Guillermet C, Brambilla C, Brambilla E: In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem 1996;44:959-968.
-
(1996)
J Histochem Cytochem
, vol.44
, pp. 959-968
-
-
Negoescu, A.1
Lorimier, P.2
Labat-Moleur, F.3
Drouet, C.4
Robert, C.5
Guillermet, C.6
Brambilla, C.7
Brambilla, E.8
-
29
-
-
33646487172
-
Actin polymerization in neutrophils from donors of peripheral blood stem cells: Divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor
-
Carulli G, Mattii L, Azzara A, Brizzi S, Galimberti S, Zucca A, Benedetti E, Petrini M: Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor. Am J Hematol 2006;81:318-323.
-
(2006)
Am J Hematol
, vol.81
, pp. 318-323
-
-
Carulli, G.1
Mattii, L.2
Azzara, A.3
Brizzi, S.4
Galimberti, S.5
Zucca, A.6
Benedetti, E.7
Petrini, M.8
-
30
-
-
0013471404
-
Cytochemical demonstration and measurement of leucocyte alkaline phosphatase activity in normal and pathological states by a modified azodye coupling technique
-
Hayhoe FG, Quaglino D: Cytochemical demonstration and measurement of leucocyte alkaline phosphatase activity in normal and pathological states by a modified azodye coupling technique. Br J Haematol 1958;4:375-389.
-
(1958)
Br J Haematol
, vol.4
, pp. 375-389
-
-
Hayhoe, F.G.1
Quaglino, D.2
-
31
-
-
0026671796
-
Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: Neutrophil alkaline phosphatase activity as an endogenous marker
-
Katoh M, Shirai T, Shikoshi K, Ishii M, Saito M, Kitagawa S: Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: neutrophil alkaline phosphatase activity as an endogenous marker. Eur J Haematol 1992;49:19-24.
-
(1992)
Eur J Haematol
, vol.49
, pp. 19-24
-
-
Katoh, M.1
Shirai, T.2
Shikoshi, K.3
Ishii, M.4
Saito, M.5
Kitagawa, S.6
-
32
-
-
0024428711
-
Introduction and overview of hematopoietic growth factors
-
Gabrilove JL: Introduction and overview of hematopoietic growth factors. Semin Hematol 1989;26:1-4.
-
(1989)
Semin Hematol
, vol.26
, pp. 1-4
-
-
Gabrilove, J.L.1
-
33
-
-
33750536034
-
Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: A comparison of filgrastim or lenograstim with pegfilgrastim
-
Schippinger W, Holub R, Dandachi N, Bauernhofer T, Samonigg H: Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim. Oncology 2006;70:290-293.
-
(2006)
Oncology
, vol.70
, pp. 290-293
-
-
Schippinger, W.1
Holub, R.2
Dandachi, N.3
Bauernhofer, T.4
Samonigg, H.5
-
34
-
-
26344453237
-
Ex vivo half-time of neutrophils from healthy human subjects pre and post treatment with daily filgrastim or single-dose pegfilgrastim
-
Allen RC: Ex vivo half-time of neutrophils from healthy human subjects pre and post treatment with daily filgrastim or single-dose pegfilgrastim. Blood 2002;100:243a.
-
(2002)
Blood
, vol.100
-
-
Allen, R.C.1
-
35
-
-
34249088890
-
Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim
-
Ribeiro D, Veldwijk MR, Benner A, Laufs S, Wenz F, Ho AD, Fruehauf S: Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim. Transfusion 2007;47:969-980.
-
(2007)
Transfusion
, vol.47
, pp. 969-980
-
-
Ribeiro, D.1
Veldwijk, M.R.2
Benner, A.3
Laufs, S.4
Wenz, F.5
Ho, A.D.6
Fruehauf, S.7
-
36
-
-
34547747858
-
PEG-filgrastim activity on granulocyte functions
-
Fazzi R, Orciuolo E, Trombi L, Mattii L, Battola B, Riccioni R, Carulli G, Galimberti S, Petrini M: PEG-filgrastim activity on granulocyte functions. Leuk Res 2007;31:1449-1455.
-
(2007)
Leuk Res
, vol.31
, pp. 1449-1455
-
-
Fazzi, R.1
Orciuolo, E.2
Trombi, L.3
Mattii, L.4
Battola, B.5
Riccioni, R.6
Carulli, G.7
Galimberti, S.8
Petrini, M.9
-
37
-
-
0030670992
-
The impact of filgrastim schedule variation on hematopoietic recovery post-chemotherapy
-
Crawford J, Kreisman H, Garewal H, Jones SE, Shoemaker D, Pupa MR, Armstrong S, Tomita D, Dziem G: The impact of filgrastim schedule variation on hematopoietic recovery post-chemotherapy. Ann Oncol 1997;8:1117-1124.
-
(1997)
Ann Oncol
, vol.8
, pp. 1117-1124
-
-
Crawford, J.1
Kreisman, H.2
Garewal, H.3
Jones, S.E.4
Shoemaker, D.5
Pupa, M.R.6
Armstrong, S.7
Tomita, D.8
Dziem, G.9
-
38
-
-
0030040434
-
Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders
-
Tsuruta T, Tani K, Shimane M, Ozawa K, Takahashi S, Tsuchimoto D, Takahashi K, Nagata S, Sato N, Asano S: Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders. Br J Haematol 1996;92:9-22.
-
(1996)
Br J Haematol
, vol.92
, pp. 9-22
-
-
Tsuruta, T.1
Tani, K.2
Shimane, M.3
Ozawa, K.4
Takahashi, S.5
Tsuchimoto, D.6
Takahashi, K.7
Nagata, S.8
Sato, N.9
Asano, S.10
-
39
-
-
0032951034
-
Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity
-
Dotti G, Garattini E, Borleri G, Masuhara K, Spinelli O, Barbui T, Rambaldi A: Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity. Br J Haematol 1999;105:163-172.
-
(1999)
Br J Haematol
, vol.105
, pp. 163-172
-
-
Dotti, G.1
Garattini, E.2
Borleri, G.3
Masuhara, K.4
Spinelli, O.5
Barbui, T.6
Rambaldi, A.7
-
40
-
-
0032400874
-
In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro
-
Leavey PJ, Sellins KS, Thurman G, Elzi D, Hiester A, Silliman CC, Zerbe G, Cohen JJ, Ambruso DR: In vivo treatment with granulocyte colony-stimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood 1998;92:4366-4374.
-
(1998)
Blood
, vol.92
, pp. 4366-4374
-
-
Leavey, P.J.1
Sellins, K.S.2
Thurman, G.3
Elzi, D.4
Hiester, A.5
Silliman, C.C.6
Zerbe, G.7
Cohen, J.J.8
Ambruso, D.R.9
-
41
-
-
0031450233
-
Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions
-
Carulli G: Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions. Haematologica 1997;82:606-616.
-
(1997)
Haematologica
, vol.82
, pp. 606-616
-
-
Carulli, G.1
-
42
-
-
24744446211
-
Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA
-
Mattii L, Azzara A, Fazzi R, Carulli G, Chimenti M, Cecconi N, Galimberti S, Petrini M: Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA. Leuk Res 2005;29:1285-1292.
-
(2005)
Leuk Res
, vol.29
, pp. 1285-1292
-
-
Mattii, L.1
Azzara, A.2
Fazzi, R.3
Carulli, G.4
Chimenti, M.5
Cecconi, N.6
Galimberti, S.7
Petrini, M.8
-
43
-
-
0026505081
-
Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis
-
Cotter TG, Lennon SV, Glynn JM, Green DR: Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 1992;52:997-1005.
-
(1992)
Cancer Res
, vol.52
, pp. 997-1005
-
-
Cotter, T.G.1
Lennon, S.V.2
Glynn, J.M.3
Green, D.R.4
-
44
-
-
0027156167
-
Impairment of function in aging neutrophils is associated with apoptosis
-
Whyte MK, Meagher LC, MacDermot J, Haslett C: Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 1993;150:5124-5134.
-
(1993)
J Immunol
, vol.150
, pp. 5124-5134
-
-
Whyte, M.K.1
Meagher, L.C.2
MacDermot, J.3
Haslett, C.4
|